Publications

Espinoza AF, Kureti P, Patel RH, Do SL, Govindu SR, Armbruster BW, Urbicain M, Patel KR, Lopez-Terrada D, Vasudevan SA, Woodfield SE.

An indocyanine green-based liquid biopsy test for circulating tumor cells for pediatric liver cancer.

Read here

Espinoza AF, Patel RH, Patel KR, Badachhape AA, Whitlock RS, Srivastava RS, Govindu SR, Duong A, Kona A, Kureti P, Armbruster P, Kats D, Dobrolecki LE, Yu X, Panah MJN, Sarabia SF, Urbicain M, Major A, Bissig KD, Keller C, Lewis MT, Heczey A, Sumazin P, Lopez-Terrada DH, Woodfield SE, Vasudevan SA.

A novel treatment strategy utilizing panobinostat for high-risk and treatment-refractory hepatoblastoma.

Read here

Patel KR, Espinoza AF, Urbicain M, Patel RH, Major A, Sarabia SF, Lopez-Terrada DH, Vasudevan SA, Woodfield SE.

Histopathological and immunophenotypic characterization of patient-derived pediatric malignant hepatocellular tumor xenografts.

Read here

Woodfield SE, Mistretta BJ, Patel RH, Ibarra AM, Fisher KE, Sarabia SF, Gandhi I, Reuther J, Starosolski Z, Badachhape A, Shah AP, Larson SR, Srivastava RK, Shi Y, Whitlock RS, Holloway K, Roy A, Ghaghada KB, Lopez-Terrada DH, Gunaratne PH, Vasudevan SA.

HepT1-derived murine models of high-risk hepatoblastoma display vascular invasion, metastasis, and circulating tumor cells.

Read here

Woodfield SE, Shi Y, Patel RH, Chen Z, Shah AP, Whitlock RS, Ibarra AM, Larson SR, Sarabia SF, Badachhape A, Starosolski Z, Ghaghada KB, Sumazin P, Annis DA, Lopez-Terrada D, Vasudevan SA.

MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma.

Read here

Whitlock RS, Yang T, Vasudevan SA, Woodfield SE.

Animal modeling of pediatric liver cancer.

Read here​